RxPG News Feed for RxPG News

Medical Research Health Special Topics World
 Asian Health
 Food & Nutrition
 Men's Health
 Mental Health
 Occupational Health
 Public Health
 Sleep Hygiene
 Women's Health
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 World Healthcare
   Latest Research
 Alternative Medicine
 Clinical Trials
 Infectious Diseases
 Sports Medicine
   Medical News
 Awards & Prizes
   Special Topics
 Odd Medical News

Last Updated: Oct 11, 2012 - 10:22:56 PM
Orthopedics Channel

subscribe to Orthopedics newsletter
Latest Research : Orthopedics

   EMAIL   |   PRINT
ACVR1 Gene Responsible for Fibrodysplasia ossificans progressiva (FOP)

Apr 25, 2006 - 8:35:00 PM , Reviewed by: Priya Saxena
The discovery of the single gene offers new hope of a first effective therapy for the disorder, they said.

[RxPG] Scientists have identified a gene that turns muscle into bone - one of the rarest disorders that affects about one in two million individuals.

The disease named by scientists as Fibrodysplasia ossificans progressiva (FOP) is a connective tissue disorder in which bone grows in tendons, ligaments, and muscles. It begins early in childhood and has no cure.

Researchers led by Frederick Kaplan at the University of Pennsylvania first established that the FOP is likely to be caused by a mutated gene that affects bone morphogenetic proteins (BMPs), which control the formation and repair of the skeleton.

This insight led them to a gene called ACVR1, which controls one of the three main receptors for BMP that determine how cells respond to its signals, the online edition of The Times reported.

In patients with FOP, a tiny mutation in one of the two copies of the ACVR1 gene changes the meaning of its genetic message, so a faulty protein is made, it said.

The discovery of the single gene offers new hope of a first effective therapy for the disorder, they said.

By providing insights into the genetic signals that govern bone growth, the research should also improve understanding and treatment of a wide range of more common skeletal conditions. These include osteoporosis, spinal injuries and sports injuries.

In the longer term, it could also allow scientists to make bone in the laboratory, for treating fractures that fail to heal and skeletal malformations.

Publication: Indo-Asian News Service

Advertise in this space for $10 per month. Contact us today.

Related Orthopedics News
Virtual models of human knee joints to study joints at tissue and cellular level
Delayed treatment of anterior cruciate ligament injuries lead to higher rates of other knee injury
Epidural steroid injections- an efficient treatment option for lumbar disc herniations
Gene in measles virus plays a key role in Paget's disease of bone
Ultrasound device speeds up broken bone healing
Programme reduces hip fractures by 37 percent
Drink tea for stronger bones, suggests study
Second SPORT Study Shows Surgery Advantage for Spinal Stenosis and Slipped Vertebra
Molecule that destroys bone also protects it, new research shows
Annual treatment with Zoledronic acid significantly reduces bone fractures

Subscribe to Orthopedics Newsletter

Enter your email address:

For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

Contact us

RxPG Online



    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)